Mid
Z
ZBHAI Stock Diagnostic Report
Zimmer Biomet forecasts 2026 adjusted EPS of $8.47-$8.59 as it raises organic revenue growth to 2.25%-3.25%
Zimmer Biomet reported strong sales in the second quarter and raised its guidance for 2026.
View Source Article ↗AI CATALYST SCORE85 / 100Score computed by Sentinel V12
REFERENCE PRICE$97.85Reference entry price at analysis time
01
FUNDAMENTALS
Financial & Fundamental Analysis
In the second quarter, net sales reached $2.177 billion, exceeding expectations, with a reported growth of 4.8% and a fixed exchange rate organic growth of 4%. The adjusted earnings per share (EPS) forecast for 2026 is projected to be between $8.47 and $8.59, and the organic revenue growth guidance has been raised to 2.25%-3.25%, demonstrating an improvement in fundamentals.
02
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
The earnings call by Zimmer Biomet (ZBH) management, which revealed a performance surprise and raised annual guidance, is acting as a short-term stock price momentum.